These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 31441292)

  • 21. Human rights mechanisms for anti-corruption, transparency and accountability: enabling the right to health.
    Sekalala S; Masud H; Bosco RT
    Glob Health Action; 2020; 13(sup1):1699343. PubMed ID: 32194016
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-corruption, Transparency and Accountability: Case Study of Healthcare in the Arab Countries.
    Hunter M; Uwaydah Mardini R; El-Seblani A; Elsayed S
    Glob Health Action; 2020; 13(sup1):1704529. PubMed ID: 32194015
    [No Abstract]   [Full Text] [Related]  

  • 23. Interventions to reduce corruption in the health sector.
    Gaitonde R; Oxman AD; Okebukola PO; Rada G
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD008856. PubMed ID: 27528494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An interdisciplinary review of digital technologies to facilitate anti-corruption, transparency and accountability in medicines procurement.
    Mackey TK; Cuomo RE
    Glob Health Action; 2020; 13(sup1):1695241. PubMed ID: 32194014
    [No Abstract]   [Full Text] [Related]  

  • 25. How Do Nigerian Newspapers Report Corruption in the Health System?
    Abba-Aji M; Balabanova D; Hutchinson E; McKee M
    Int J Health Policy Manag; 2021 Feb; 10(2):77-85. PubMed ID: 32610718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting anticorruption interventions at the front line: developmental governance in health systems.
    Hutchinson E; Naher N; Roy P; McKee M; Mayhew SH; Ahmed SM; Balabanova D
    BMJ Glob Health; 2020 Dec; 5(12):. PubMed ID: 33272939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [COUNTERACTION TO CORRUPTION DURING PUBLIC PROCUREMENT OF MEDICINAL PRODUCTS].
    Lohvynenko B; Podoliaka A; Domin Y; Kolesnikova I; Salaieva K
    Georgian Med News; 2022 Feb; (323):175-179. PubMed ID: 35271492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoting anti-corruption, transparency and accountability in the recruitment and promotion of health workers to safeguard health outcomes.
    Kirya MT
    Glob Health Action; 2020; 13(sup1):1701326. PubMed ID: 32194012
    [No Abstract]   [Full Text] [Related]  

  • 29. We Need to Talk About Corruption in Health Systems.
    Hutchinson E; Balabanova D; McKee M
    Int J Health Policy Manag; 2019 Apr; 8(4):191-194. PubMed ID: 31050963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The sustainable development goals as a framework to combat health-sector corruption.
    Mackey TK; Vian T; Kohler J
    Bull World Health Organ; 2018 Sep; 96(9):634-643. PubMed ID: 30262945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Individual and Institutional Corruption in European and US Healthcare: Overview and Link of Various Corruption Typologies.
    Sommersguter-Reichmann M; Wild C; Stepan A; Reichmann G; Fried A
    Appl Health Econ Health Policy; 2018 Jun; 16(3):289-302. PubMed ID: 29572725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [PREVENTION OF CORRUPTION OFFENCES IN THE HEALTHСARE: THE EXPERIENCE OF UKRAINE AND GEORGIA].
    Didkivska G; Kovalenko V; Fialka M; Samotiievych V; Sabadash I
    Georgian Med News; 2020 Nov; (308):185-191. PubMed ID: 33395665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Addressing health corruption during a public health crisis through anticipatory governance: Lessons from the COVID-19 pandemic.
    Gonzalez-Aquines A; Kowalska-Bobko I
    Front Public Health; 2022; 10():952979. PubMed ID: 35968489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations.
    Gorodensky A; Bowra A; Saeed G; Kohler J
    BMJ Open; 2022 Dec; 12(12):e064137. PubMed ID: 36549737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "It Keeps Us from Putting Drugs in Pockets": How a Public-Private Partnership for Hospital Management May Help Curb Corruption.
    Vian T; Mcintosh N; Grabowski A
    Perm J; 2017; 21():16-113. PubMed ID: 28746025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corruption and strengthening anti-corruption efforts in healthcare during the pandemic of Covid-19.
    Teremetskyi V; Duliba Y; Kroitor V; Korchak N; Makarenko O
    Med Leg J; 2021 Mar; 89(1):25-28. PubMed ID: 33331228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of corruption and governance in the delivery of frontline health care services in the public sector: a scoping review of current and future prospects in low and middle-income countries of south and south-east Asia.
    Naher N; Hoque R; Hassan MS; Balabanova D; Adams AM; Ahmed SM
    BMC Public Health; 2020 Jun; 20(1):880. PubMed ID: 32513131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Corruption, public trust and medical autonomy in the public health sector of Montenegro: Taking stock of the COVID-19 influence.
    Radević I; Alfirević N; Lojpur A
    PLoS One; 2022; 17(9):e0274318. PubMed ID: 36074759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corruption in the health care sector: A barrier to access of orthopaedic care and medical devices in Uganda.
    Bouchard M; Kohler JC; Orbinski J; Howard A
    BMC Int Health Hum Rights; 2012 May; 12():5. PubMed ID: 22554349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Where Do We Start? Building Consensus on Drivers of Health Sector Corruption in Nigeria and Ways to Address It.
    Onwujekwe O; Orjiakor CT; Hutchinson E; McKee M; Agwu P; Mbachu C; Ogbozor P; Obi U; Odii A; Ichoku H; Balabanova D
    Int J Health Policy Manag; 2020 Jul; 9(7):286-296. PubMed ID: 32613800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.